NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc.  (NASDAQ: PRPO)  is requesting that shareholders instruct their brokers to...
NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that it will be presenting at the Planet MicroCap Las Vegas...
NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces financial results for the first quarter ended March 31, 2026....
NEW HAVEN, Conn., May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.  (NASDAQ: PRPO) announces that 2025 employee stock options granted to certain members of...
NEW HAVEN, Conn., May 06, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. Â (NASDAQ: PRPO) , will be hosting its Q1-2026 shareholder update call on May 18 th , 2026,...
NEW HAVEN, Conn., March 12, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. Â (NASDAQ: PRPO) , will be hosting its Q4 and year end 2025 corporate update call on April 2...
NEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. Â (NASDAQ: PRPO) has announced the publication 1 in the Journal of Clinical Pathology...
NEW HAVEN, Conn., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces some preliminary (unaudited) financials for Q4-2025 and for...
NEW HAVEN, Conn., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. Â (NASDAQ: PRPO) has made major strides in cleaning up its balance sheet with two major...
NEW HAVEN, Conn., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.  (NASDAQ: PRPO) will be presenting at ASH the findings of a joint study conducted with...